Speaker: Insoo Kang, MD

Title: Anti-nuclear antibody and Lupus

Date: 05/15/2026

Time: 8:30AM

Location: Bizzozero Conference Room. 

Session Attendance Code: WUVGUF

 

Session Learning Objectives:  Participants will (be able to):

1.  Explain how ANAs are measured.

2.  Identify the clinical significance of positive in general population and patients with lupus.

3.  Explain how ANAs can cause inflammation in lupus.

 

Speaker Disclosure Statement: Insoo Kang, MD for this educational event, has a financial relationship(s) with Eli Lilly and Company, that could be perceived as a real or apparent conflict of interest in the context of their role as the [speaker]. The following mitigated safeguard(s) have been put into place: The activity director determined that the financial relationship of the speaker is outside the area of the content of the program. All the relevant financial relationships listed for this individual have been mitigated.

 

Target Audience: Faculty, staff, residents, and students interested in clinical research.

Accreditation: The University of Connecticut School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Connecticut School of Medicine designates this [live activity] for a maximum of _ [1] _ AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Conflict of Interest Policy: All faculty members participating in CME activities provided by the University of Connecticut School of Medicine are required to disclose to the program audience any actual or apparent conflict of interest related to the content of their presentations. Program planners have an obligation to resolve any actual conflicts of interest and share with the audience any safeguards put in place to prevent commercial bias from influencing the content.

Activity Directors & Planning Committee Disclosure Statement: Neither the activity director, the activity administrator, nor the planning committee members in their role as planning committee members for this educational event, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. There are no relevant financial relationships listed for these individuals to be mitigated.

Commercial Support Statement: This CME activity has no commercial support associated with it.